Source: Annual Congress 2012 - New biomarkers for lung cancer
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. L. Lau, E. Duan, J. L. McQualter, G. P. Anderson, M. L. Hibbs (Melbourne, Australia). Increased activity of Lyn tyrosine kinase causes multiple chronic obstructive pulmonary disease-like changes in mouse. Eur Respir J 2012; 40: Suppl. 56, 4222

Member's Comments

No comment yet.

Related content which might interest you: Inhibition of c-kit tyrosine kinase by sunitinib alleviates airway remodeling in a mouse model of chronic asthma Source: Annual Congress 2009 - Preclinical models in drug development Year: 2009 The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis Source: Eur Respir J 2015; 45: 1426-1433 Year: 2015 Btk (Bruton’s tyrosine kinase) in B cells is overexpressed in patients with idiopathic pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Increased activation of p38 MAPK in COPD Source: Eur Respir J 2008; 31: 62-69 Year: 2008 Epigenetic-like regulation of signalling proteins in chronic obstructive pulmonary disease Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms Year: 2019 Targeting the mTOR signaling pathway to inhibit lung cell senescence in chronic obstructive pulmonary disease (COPD) Source: ERS Lung Science Conference 2017 Year: 2017 Pulmonary complications of tyrosine kinase inhibitors in myeloproliferative disorders Source: Eur Respir J, 56 (4) 2002653; 10.1183/13993003.02653-2020 Year: 2020 Chronic stress affects lung sphingosine kinase isoenzymes and increases the risk of lung infections Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010 PP208 – SRC family kinases modulate molecular pathways associated with mitochondrial dysfunction in idiopathic pulmonary fibrosis Source: ERS Lung Science Conference 2021 Year: 2021 Plasma receptor tyrosine kinase RET in pulmonary arterial hypertension diagnosis and differentiation Source: ERJ Open Res, 5 (4) 00037-2019; 10.1183/23120541.00037-2019 Year: 2019 Anti IL-17 with or without Rho kinase inhibitor in mice with chronic allergic pulmonary inflammation Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017 Expression of the MET receptor kinase is a potential functional marker of Idiopathic pulmonary fibrosis Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis Year: 2017 Homeodomain-interracting protein kinase 2 (HIPK2) in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Role of IκB kinases (IKKs) α and β in severe asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 2s Year: 2005 Increased rho-kinase activity is related to pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Corticosteroid insensitivity and enhanced mitogen-activated protein kinase activity in airway smooth muscle cells of severe asthma Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology Year: 2011 Mice deficient in Raf kinase inhibitor protein (RKIP) have elevated indices of pulmonary hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Involvement of cytoskeletal protein paxillin in the pathogenesis of pulmonary hypertension Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 SRC family kinase inhibition reduces NOX4 expression in bronchial epithelial cells from Idiopathic Pulmonary Fibrosis patients Source: International Congress 2019 – Damage and remodelling in pulmonary fibrosis Year: 2019